Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 1, Janvier 2005
Page(s) 89 - 94
Section Dossier technique
DOI https://doi.org/10.1051/medsci/200521189
Publié en ligne 15 janvier 2005
  1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 : 693–9.
  2. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced stage hepatocellular carcinoma. Hepatology 1995; 21 : 403–7.
  3. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214 : 114–7.
  4. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 223 : 652–9.
  5. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure : definitions and causes. Semin Liver Dis 1986; 6 : 97–106.
  6. Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation 2001; 72 : 177–81.
  7. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72 : 1684–8.
  8. Trotter JF, Talamantes M, McClure M, et al. Right hepatic lobe donation for living donor liver transplantation : impact on donor quality of life. Liver Transpl 2001; 7 : 485–93.
  9. Toso C, Ris F, Mentha G, et al. Potential impact of in situ liver splitting on the number of available grafts. Transplantation 2002; 74 : 222–6.
  10. O’grady JG, Burroughs A, Hardy P, et al. Tacrolimus versus microemulsified ciclosporin in liver transplantation : the TMC randomised controlled trial. Lancet 2002; 360 : 1119–25.
  11. Boillot O, Viale JP, Gratadour P, et al. Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation : a pilot study. Transplantation 1998; 66 : 1182–5.
  12. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection : incidence, risk factors and impact on outcome. Hepatology 1998; 28 : 638–45.
  13. Shirwan H. Chronic allograft rejection. Transplantation 1999; 68 : 715–26.
  14. Schlitt HJ, Barkmann A, Boker KHW, et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver transplant patients with renal dysfunction : a randomised controlled study. Lancet 2001; 357 : 587–91.
  15. Denys AL, Qanadli SD, Durand F, et al. Feasibility and effectiveness of using coronary stents in the treatment of hepatic artery stenoses after orthotopic liver transplantation : preliminary report. Am J Roentgenol 2002; 178 : 1175–9.
  16. Sawyer SG, Punch JD. Incidence and management of biliary complications after 291 following the introduction of transcystic stenting. Transplantation 1998; 66 : 1201–7.
  17. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation : increase in recent years. J Hepatol 2000; 32 : 673–84.
  18. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51 : 248–52.
  19. Lavezzo B, Franchello A, Smedile A, et al. Treatment of recurrent hepatitis C in liver transplants : efficacy of a six versus twelve month course of interferon alfa 2b with ribavirin. J Hepatol 2002; 37 : 247–52.
  20. Lo CM, Fan ST, Liu CL, et al. Prophylaxis and treatment of recurrent hepatitis B virus infection after liver transplantation. Transplantation 2003; 75 : S41–4.
  21. Fontana RJ, Hann HW, Wright T, et al. A multicenter study of lamivudine treatment of 33 patients with hepatitis B after liver transplantation. Liver Transpl 2001; 7 : 504–10.
  22. Gerhardt TC, Goldstein RM, Urschel HC, et al. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996; 62 : 1060–3.
  23. Selzner N, Durand F, Bernuau J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients : a combined north american and european experience. Transplantation 2001; 72 : 1061–5.
  24. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349 : 931–40.
  25. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits ? Transplantation 1997; 64 : 1261–73.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.